These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 16537629)
1. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. Martinez-Picado J; Prado JG; Fry EE; Pfafferott K; Leslie A; Chetty S; Thobakgale C; Honeyborne I; Crawford H; Matthews P; Pillay T; Rousseau C; Mullins JI; Brander C; Walker BD; Stuart DI; Kiepiela P; Goulder P J Virol; 2006 Apr; 80(7):3617-23. PubMed ID: 16537629 [TBL] [Abstract][Full Text] [Related]
2. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations. Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617 [TBL] [Abstract][Full Text] [Related]
3. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. Brockman MA; Schneidewind A; Lahaie M; Schmidt A; Miura T; Desouza I; Ryvkin F; Derdeyn CA; Allen S; Hunter E; Mulenga J; Goepfert PA; Walker BD; Allen TM J Virol; 2007 Nov; 81(22):12608-18. PubMed ID: 17728232 [TBL] [Abstract][Full Text] [Related]
4. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function. Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081 [TBL] [Abstract][Full Text] [Related]
5. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity. Tsai MC; Singh S; Adland E; Goulder P J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820 [TBL] [Abstract][Full Text] [Related]
6. HIV-1 replication fitness of HLA-B*57/58:01 CTL escape variants is restored by the accumulation of compensatory mutations in gag. Gijsbers EF; Feenstra KA; van Nuenen AC; Navis M; Heringa J; Schuitemaker H; Kootstra NA PLoS One; 2013; 8(12):e81235. PubMed ID: 24339913 [TBL] [Abstract][Full Text] [Related]
7. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. Crawford H; Lumm W; Leslie A; Schaefer M; Boeras D; Prado JG; Tang J; Farmer P; Ndung'u T; Lakhi S; Gilmour J; Goepfert P; Walker BD; Kaslow R; Mulenga J; Allen S; Goulder PJ; Hunter E J Exp Med; 2009 Apr; 206(4):909-21. PubMed ID: 19307327 [TBL] [Abstract][Full Text] [Related]
8. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. Troyer RM; McNevin J; Liu Y; Zhang SC; Krizan RW; Abraha A; Tebit DM; Zhao H; Avila S; Lobritz MA; McElrath MJ; Le Gall S; Mullins JI; Arts EJ PLoS Pathog; 2009 Apr; 5(4):e1000365. PubMed ID: 19343217 [TBL] [Abstract][Full Text] [Related]
9. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes. Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R mBio; 2017 Nov; 8(6):. PubMed ID: 29184023 [TBL] [Abstract][Full Text] [Related]
10. Maternal transmission of human immunodeficiency virus escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant. Schneidewind A; Tang Y; Brockman MA; Ryland EG; Dunkley-Thompson J; Steel-Duncan JC; St John MA; Conrad JA; Kalams SA; Noel F; Allen TM; Christie CD; Feeney ME J Virol; 2009 Sep; 83(17):8616-27. PubMed ID: 19515764 [TBL] [Abstract][Full Text] [Related]
11. Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication. Wagner R; Leschonsky B; Harrer E; Paulus C; Weber C; Walker BD; Buchbinder S; Wolf H; Kalden JR; Harrer T J Immunol; 1999 Mar; 162(6):3727-34. PubMed ID: 10092836 [TBL] [Abstract][Full Text] [Related]
12. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. Goulder PJ; Brander C; Annamalai K; Mngqundaniso N; Govender U; Tang Y; He S; Hartman KE; O'Callaghan CA; Ogg GS; Altfeld MA; Rosenberg ES; Cao H; Kalams SA; Hammond M; Bunce M; Pelton SI; Burchett SA; McIntosh K; Coovadia HM; Walker BD J Virol; 2000 Jun; 74(12):5679-90. PubMed ID: 10823876 [TBL] [Abstract][Full Text] [Related]
13. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient. Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738 [TBL] [Abstract][Full Text] [Related]
14. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253 [TBL] [Abstract][Full Text] [Related]
15. Functional consequences of human immunodeficiency virus escape from an HLA-B*13-restricted CD8+ T-cell epitope in p1 Gag protein. Prado JG; Honeyborne I; Brierley I; Puertas MC; Martinez-Picado J; Goulder PJ J Virol; 2009 Jan; 83(2):1018-25. PubMed ID: 18945768 [TBL] [Abstract][Full Text] [Related]
16. Temporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progression. Ntale RS; Chopera DR; Ngandu NK; Assis de Rosa D; Zembe L; Gamieldien H; Mlotshwa M; Werner L; Woodman Z; Mlisana K; Abdool Karim S; Gray CM; Williamson C; J Virol; 2012 Nov; 86(22):12013-24. PubMed ID: 22933291 [TBL] [Abstract][Full Text] [Related]
17. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection. Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634 [TBL] [Abstract][Full Text] [Related]
18. HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome. Ammaranond P; van Bockel DJ; Petoumenos K; McMurchie M; Finlayson R; Middleton MG; Davenport MP; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD J Immunol; 2011 Jan; 186(1):479-88. PubMed ID: 21115730 [TBL] [Abstract][Full Text] [Related]
19. Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein. Boutwell CL; Rowley CF; Essex M J Virol; 2009 Mar; 83(6):2460-8. PubMed ID: 19109381 [TBL] [Abstract][Full Text] [Related]
20. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope. Nietfield W; Bauer M; Fevrier M; Maier R; Holzwarth B; Frank R; Maier B; Riviere Y; Meyerhans A J Immunol; 1995 Mar; 154(5):2189-97. PubMed ID: 7868892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]